ArticleJournal of translational medicine2016

PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.

Xiao-Bin Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.